These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8635932

  • 1. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
    Stock RG, Stone NN, Iannuzzi C.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):267-72. PubMed ID: 8635932
    [Abstract] [Full Text] [Related]

  • 2. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG, Stone NN, DeWyngaert JK, Lavagnini P, Unger PD.
    Cancer; 1996 Jun 01; 77(11):2386-92. PubMed ID: 8635111
    [Abstract] [Full Text] [Related]

  • 5. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 6. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul 01; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 7. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
    Stock RG, Kao J, Stone NN.
    J Urol; 2001 Feb 01; 165(2):436-9. PubMed ID: 11176391
    [Abstract] [Full Text] [Related]

  • 8. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 01; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 9. Five-year potency preservation after iodine-125 prostate brachytherapy.
    Nishimura S, Yorozu A, Ohashi T, Sakayori M, Yagi Y, Nishiyama T, Saito S, Shiraishi Y, Yoshida K, Toya K, Shigematsu N.
    Int J Clin Oncol; 2014 Oct 01; 19(5):940-5. PubMed ID: 24170247
    [Abstract] [Full Text] [Related]

  • 10. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 11. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate.
    Raina R, Agarwal A, Goyal KK, Jackson C, Ulchaker J, Angermeier K, Klein E, Ciezki J, Zippe CD.
    Urology; 2003 Dec 01; 62(6):1103-8. PubMed ID: 14665364
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potency after permanent prostate brachytherapy for localized prostate cancer.
    Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1235-42. PubMed ID: 11483334
    [Abstract] [Full Text] [Related]

  • 14. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]

  • 15. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
    Merrick GS, Butler WM, Galbreath RW, Lief JH.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):41-8. PubMed ID: 11516849
    [Abstract] [Full Text] [Related]

  • 16. Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.
    Ong WL, Hindson BR, Beaufort C, Pharoah P, Millar JL.
    Radiother Oncol; 2014 Jul 01; 112(1):72-6. PubMed ID: 25086852
    [Abstract] [Full Text] [Related]

  • 17. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):e765-71. PubMed ID: 22300559
    [Abstract] [Full Text] [Related]

  • 18. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
    Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ.
    Brachytherapy; 2015 Apr 01; 14(2):160-5. PubMed ID: 25255712
    [Abstract] [Full Text] [Related]

  • 19. Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity.
    Merrick GS, Butler WM, Wallner K, Galbreath RW, Anderson RL, Kurko BS, Lief JH.
    Urology; 2002 Jul 01; 60(1):104-8. PubMed ID: 12100933
    [Abstract] [Full Text] [Related]

  • 20. Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer.
    Bazinet A, Zorn KC, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2020 Jul 01; 19(2):222-227. PubMed ID: 31837989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.